Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of topical Veregen for vulval intraepithelial neoplasia
2013-003107-19Phase 2Completed
- Sponsor
- University of Birmingham
- Start
- Apr 2014
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sinecatechins in vulvar intraepithelial neoplasia (VIN), sponsored by University of Birmingham. Primary endpoint: Histological resolution of VIN. Started Apr 2014; status: completed.
02
Drugs
sinecatechins
03
Conditions
vulvar intraepithelial neoplasia (VIN)
Beyond the preview
Go deeper on 2013-003107-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003107-19.